Authors: Aamdal, S Lund, B Koier, I Houten, M Wanders, J Verweij, J

Citation: S. Aamdal et al., Phase I trial with weekly EO9, a novel bioreductive alkylating indoloquinone, by the EORTC Early Clinical Study Group (ECSG), CANC CHEMOT, 45(1), 2000, pp. 85-88